Deng, J., Bai, X., Feng, X., Ni, J., Beretov, J., Graham, P., & Li, Y. (2019). Inhibition of PI3K/Akt/mTOR signaling pathway alleviates ovarian cancer chemoresistance through reversing epithelial-mesenchymal transition and decreasing cancer stem cell marker expression. BMC Cancer.
Citação norma ChicagoDeng, Junli, Xupeng Bai, Xiaojie Feng, Jie Ni, Julia Beretov, Peter Graham, and Yong Li. "Inhibition of PI3K/Akt/mTOR Signaling Pathway Alleviates Ovarian Cancer Chemoresistance Through Reversing Epithelial-mesenchymal Transition and Decreasing Cancer Stem Cell Marker Expression." BMC Cancer 2019.
Citação norma MLADeng, Junli, et al. "Inhibition of PI3K/Akt/mTOR Signaling Pathway Alleviates Ovarian Cancer Chemoresistance Through Reversing Epithelial-mesenchymal Transition and Decreasing Cancer Stem Cell Marker Expression." BMC Cancer 2019.